COMPANY

Acuitive Technologies

HQ: Allendale, NJ source · acuitivetech.com ↗ · Mid-Atlantic

Keywords: musculoskeletal

Location: Allendale, NJ · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $1.88M (Form D filed Sep 24, 2026). SEC Form D 0001864239-26-000004 (Sep 24, 2026)
Evidence (1 event)
- Sep 24, 2026 · SEC Form D 0001864239-26-000004
  Name of Issuer: Acuitive Technologies, Inc.; CIK: 1864239; Address: Allendale, NJ; Submission type: D; Filing date: 2026-09-24; Industry Group: Other Health Care; Date of First Sale: 2026-08-14; Types of Securities Offered: Other (Simple Agreements for Future Equity (SAFEs)); Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 1875000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Nov 6, 2024 FDA FDA 510(k) clearance: Citrepore — K240450, Nov 6, 2024. Applicant at approval: Acuitive Technologies, Inc. source ↗

Nov 6, 2024 FDA 510(k) clearance: Citrepore — K240450, Nov 6, 2024. Applicant at approval: Acuitive Technologies, Inc. source ↗

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12